|
83
|
298
|
3qxpA |
Cdk2 in complex with inhibitor rc-3-89 |
|
80
|
298
|
3qwkA |
Cdk2 in complex with inhibitor kvr-1-150 |
|
79
|
298
|
3qtxA |
Cdk2 in complex with inhibitor rc-2-35 |
|
89
|
286
|
3qd0A |
Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with (2r,5s)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-6-methyl-n-phenyl-3-piperidinecarboxamide |
|
77
|
298
|
3qtrA |
Cdk2 in complex with inhibitor rc-1-148 |
|
88
|
263
|
3qrjA |
The crystal structure of human abl1 kinase domain t315i mutant in complex with dcc-2036 |
|
82
|
274
|
3qf9A |
Crystal structure of human proto-oncogene serine threonine kinase (pim1) in complex with a consensus peptide and a furan-thiazolidinedione ligand |
|
106
|
349
|
3queA |
Human p38 map kinase in complex with skepinone-l |
|
81
|
286
|
3qcxA |
Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 6-{2-amino-6-[(3r)-3-methyl-4-morpholinyl]-4-pyrimidinyl}-1h-indazol-3-amine |
|
81
|
286
|
3qcsA |
Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 6-[2-amino-6-(4-morpholinyl)-4-pyrimidinyl]-1h-indazol-3-amine |
|
85
|
298
|
3qqlA |
Cdk2 in complex with inhibitor l3 |
|
82
|
298
|
3qruA |
Cdk2 in complex with inhibitor nsk-mc1-12 |
|
98
|
335
|
3qkmA |
Spirocyclic sulfonamides as akt inhibitors |
|
77
|
298
|
3qx4A |
Cdk2 in complex with inhibitor kvr-1-78 |
|
131
|
651
|
3qa8A |
Crystal structure of inhibitor of kappa b kinase beta |
|
75
|
298
|
3qtqA |
Cdk2 in complex with inhibitor rc-1-137 |
|
78
|
298
|
3qwjA |
Cdk2 in complex with inhibitor kvr-1-142 |
|
74
|
261
|
3qgwA |
Crystal structure of itk kinase bound to an inhibitor |
|
77
|
284
|
3qupA |
Inhibitor bound structure of the kinase domain of the murine receptor tyrosine kinase tyro3 (sky) |
|
85
|
288
|
3qd4A |
Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 1,1-dimethylethyl{(3r,5r)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-5-methyl-3-piperidinyl}carbamate |
|
81
|
286
|
3qcqA |
Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 6-(3-amino-1h-indazol-6-yl)-n4-ethyl-2,4-pyrimidinediamine |
|
85
|
298
|
3qrtA |
Cdk2 in complex with inhibitor nsk-mc2-55 |
|
74
|
276
|
3qlgA |
Crystal structure of the l317i mutant of the c-src tyrosine kinase domain complexed with dasatinib |
|
78
|
264
|
3qgyA |
Crystal structure of itk inhibitor complex |
|
77
|
298
|
3qtwA |
Cdk2 in complex with inhibitor rc-2-13 |
|
87
|
288
|
3qd3A |
Phosphoinositide-dependent kinase-1 (pdk1) kinase domain with 1,1-dimethylethyl {(3r,6s)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-6-methyl-3-piperidinyl}carbamate |
|
83
|
298
|
3qqgA |
Cdk2 in complex with inhibitor l2-5 |
|
97
|
335
|
3qklA |
Spirochromane akt inhibitors |
|
88
|
298
|
3qhrA |
Structure of a pcdk2/cyclina transition-state mimic |
|
162
|
503
|
3qc9A |
Crystal structure of cross-linked bovine grk1 t8c/n480c double mutant complexed with adp and mg |
|
85
|
275
|
3qriA |
The crystal structure of human abl1 kinase domain in complex with dcc-2036 |
|
73
|
276
|
3qlfA |
Crystal structure of the l317i mutant of the c-src tyrosine kinase domain complexed with pyrazolopyrimidine 5 |
|
99
|
335
|
3qkkA |
Spirochromane akt inhibitors |
|
81
|
298
|
3qx2A |
Cdk2 in complex with inhibitor kvr-1-190 |
|
90
|
309
|
3qtiA |
C-met kinase in complex with nvp-bvu972 |
|
113
|
328
|
3pzhA |
Crystal structure of maize ck2 alpha in complex with emodin at 1.92 a resolution |
|
85
|
269
|
3pyyA |
Discovery and characterization of a cell-permeable, small-molecule c-abl kinase activator that binds to the myristoyl binding site |
|
106
|
350
|
3qalE |
Crystal structure of arg280ala mutant of catalytic subunit of camp-dependent protein kinase |
|
107
|
330
|
3qa0A |
Crystal structure of the apo-form of human ck2 alpha at ph 6.5 |
|
99
|
352
|
3q3bA |
6-amino-4-(pyrimidin-4-yl)pyridones: novel glycogen synthase kinase-3 inhibitors |
|
82
|
298
|
3pxyA |
Cdk2 in complex with inhibitor jws648 |
|
114
|
332
|
3q9zA |
Crystal structure of human ck2 alpha in complex with quinalizarin at ph 6.5 |
|
96
|
305
|
3q4tA |
Crystal structure of activin receptor type-iia (acvr2a) kinase domain in complex with dorsomorphin |
|
68
|
276
|
3q4cA |
Crystal structure of wild type braf kinase domain in complex with organometallic inhibitor cns292 |
|
198
|
640
|
3pvwA |
Bovine grk2 in complex with gbetagamma subunits and a selective kinase inhibitor (cmpd103a) |
|
109
|
356
|
3pzeA |
Jnk1 in complex with inhibitor |
|
88
|
298
|
3py0A |
Cdk2 in complex with inhibitor su9516 |
|
116
|
350
|
3qamE |
Crystal structure of glu208ala mutant of catalytic subunit of camp-dependent protein kinase |
|
111
|
328
|
3q04A |
Crystal structure of the apo-form of human ck2 alpha at ph 8.5 |
|
65
|
263
|
3qbnA |
Structure of human aurora a in complex with a diaminopyrimidine |
